Instrumems Announces New Bubble Detection Sensor

Instrumems a pioneer in smart multi-sensor solutions, announced its new Bubble detection sensor today. Easy to integrate into existing liquid control systems, Instrumems’ bubble detection technology is a new measurement system for improved precision in liquid handling, leading to reduced errors.

Engineering teams and system architects will benefit from the efficiency of the sensor’s fast response to quantify micro-size bubbles occupying <50% of a channel. The biocompatibility of Instrumems’ Bubble detection sensor provides a new solution to various areas (i.e., Life Sciences, Pharma, food testing, etc.) with a safe and accurate flow measurement.

Instrumems’ new Bubble detection sensor increases the product yield or the accuracy of the material delivery and reduces equipment downtime through early indication of liquid blockage or leaks. The improved equipment design and measurement capabilities result in enhanced liquid delivery control systems. Instrumems’ bubble detector squarely addresses a few ongoing problems that select industry manufacturers face, including:

  • Liquid flow control: Ensures valve closure, so no leaks occur.
  • Integrated equipment: Delivers visibility into areas inaccessible to the user or not easily serviced.
  • Additive manufacturing: Identifies blocks and provides data for improved control and delivery of the material.

The company’s core technology is based on a novel MEMS-based nano thermal filament used for accurate flow measurement. Its bubble detection technology applies the principle to liquid flows. It uses the sensor’s fast response to a phase change (liquid-gas-liquid) to detect micro air bubbles.

The new bubble detection technology is ideal for food processing (i.e., food safety analysis), additive manufacturing (i.e., 3D printers), life sciences (i.e., microfluidic control in labs), and medical applications (i.e., dialysis, drug delivery). Comparable alternatives like ultrasonic sensors are 5x the cost with restrictions on tube types and accuracy. And with Instrumems, there are no constraints with tube material or thickness, while the tiny form factor makes it easy to integrate into small tubes. Key features of Instrumems’ bubble detection technology include:

  • Bubbles detection: <50% occupied channel (only product to do this)
  • Fast response time: <1ms (fastest response on the market)
  • Bubble detection at low flow rates: +/- 0.5ml/min

“I’m delighted to announce this new product to our customers and the market. It provides the most advanced measurement system to deliver precise quantities of liquid components across various industries,” said Gilad Arwatz, Instrumems’ founder and CEO. “We’re committed to digitizing the data to give real-time visibility and control in areas where it was impossible previously due to constraints in form factor, battery life, cost, speed, and accuracy of the sensor.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.